No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
GTBP GT Biopharma
- 3.5901
- -0.1599-4.26%
Trading Jun 3 10:22 ET
7.74MMarket Cap-507P/E (TTM)
3.7809High3.5500Low29.15KVolume3.7600Open3.7500Pre Close105.99KTurnover1.60%Turnover RatioLossP/E (Static)2.16MShares14.370052wk High1.46P/B6.54MFloat Cap2.953952wk Low--Dividend TTM1.82MShs Float591.9900Historical High--Div YieldTTM6.16%Amplitude2.9530Historical Low3.6360Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersIGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday's regular session. The market value of their outstanding shares is at $678.1 million. Akso Health Group (NASDA
CureVac, Oragenics, IGM Biosciences Among Healthcare Movers
PLAB, MMAT and HBM Among Pre-market Losers
Biodexa BDRX Data; GT Biopharma GTBP Offering
Top Midday Decliners
GT Biopharma (GTBP) said Tuesday it priced a registered direct offering of 740,000 shares at $4.35 per share to raise about $3.2 million for general corporate purposes. It will also issue warrants in
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 84.3% to $2.34 during Tuesday's regular session. The market value of their outstanding shares is at $10.2 million. Genelux (NASDAQ:GNLX)
Comments
GT Biopharma Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules.
GT Biopharma, Inc. (NASDAQ: GTBP) recently announced a major development with the entry into definitive securities purchase agreements for a registered direct offering priced at-the-market under Nasdaq rules. The company disclosed that it has secured the purchase and sale of 740,000 shares of its common stock at...
GT Biopharma, Inc. (NASDAQ: GTBP) recently announced a major development with the entry into definitive securities purchase agreements for a registered direct offering priced at-the-market under Nasdaq rules. The company disclosed that it has secured the purchase and sale of 740,000 shares of its common stock at...
$GT Biopharma(GTBP.US$ $Edible Garden(EDBL.US$ $Cheetah Net Supply Chain Service(CTNT.US$ Lets move to a better place before crash
$Cue Health(HLTH.US$ UPUPUPUP
$Cue Health(HLTH.US$ UPUPUPUP
2
1
$GT Biopharma(GTBP.US$ is this the end?! Good ride
$GT Biopharma(GTBP.US$ do when it goes up circuit break lol
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg